DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020
October 28 2020 - 8:30AM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that
its third quarter 2020 financial results will be released after the
markets close on Wednesday, November 4th. DiaMedica will host a
live conference call on Thursday, November 5th at 7:00 AM Central
Time to discuss its business update and financial results.
Conference Call details:
Date:
Thursday, November 5, 2020
Time:
7:00 AM CT / 8:00 AM ET
Web access:
https://event.on24.com/wcc/r/2623032/5A77F53289171F7E16245B392065B627
Dial In:
(866) 393-4306 (domestic)
(734) 385-2616 (international)
Conference ID:
4869514
Interested parties may access the conference call by dialing in
or listening to the simultaneous webcast. Listeners should log on
to the website or dial in 15 minutes prior to the call. The webcast
will remain available for play back on DiaMedica’s website, under
investor events and presentations, following the earnings call and
for 12 months thereafter. A telephonic replay of the conference
call will be available until November 12, 2020, by dialing (855)
859-2056 (US Toll Free), (404) 537-3406 (International), replay
passcode 4869514.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. DiaMedica’s
shares are listed on The Nasdaq Capital Market under the trading
symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201028005187/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024